These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31262748)

  • 1. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury.
    Villar-Lorenzo A; Rada P; Rey E; Marañón P; Arroba AI; Santamaría B; Sáiz J; Rupérez FJ; Barbas C; García-Monzón C; Valverde ÁM; González-Rodríguez Á
    Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31262748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of hepatic stellate cell and fibroblast-derived LOXL1 attenuates BDL- and
    Yan X; Zhang N; Wei L; Zhang W; Huang T; Li W; Chen W; Yang A; You H
    Am J Physiol Gastrointest Liver Physiol; 2023 Dec; 325(6):G608-G621. PubMed ID: 37873581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
    Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
    Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
    Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
    Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
    Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
    PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury.
    Sommer J; Dorn C; Gäbele E; Bataille F; Freese K; Seitz T; Thasler WE; Büttner R; Weiskirchen R; Bosserhoff A; Hellerbrand C
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
    Uchinami H; Seki E; Brenner DA; D'Armiento J
    Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
    Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
    Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of necroptosis in human and experimental cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
    Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
    Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
    Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats.
    Eshaghian A; Khodarahmi A; Safari F; Binesh F; Moradi A
    Br J Nutr; 2018 Aug; 120(4):393-403. PubMed ID: 29880071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
    Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
    Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.
    Kennedy LL; Meng F; Venter JK; Zhou T; Karstens WA; Hargrove LA; Wu N; Kyritsi K; Greene J; Invernizzi P; Bernuzzi F; Glaser SS; Francis HL; Alpini G
    Lab Invest; 2016 Dec; 96(12):1256-1267. PubMed ID: 27775690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases.
    García-Ruiz I; Blanes Ruiz N; Rada P; Pardo V; Ruiz L; Blas-García A; Valdecantos MP; Grau Sanz M; Solís Herruzo JA; Valverde ÁM
    Redox Biol; 2019 Sep; 26():101263. PubMed ID: 31299613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
    Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
    Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
    Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
    Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.